ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. It operates through the following geographical segments: United States, Germany, and Rest of the World. The firm's products include iUni, iDuo, iTotal CR, and iTotal. The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Conformis Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Conformis Inc. market cap is $17.8M.
What is the 52-week high for Conformis Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Conformis Inc. 52 week high is $7.25 as of September 09, 2025.
What is the 52-week low for Conformis Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Conformis Inc. 52 week low is $1.05 as of September 09, 2025.
What is Conformis Inc. stock price today?
Conformis Inc. stock price today is $2.27.
What was Conformis Inc. stock price yesterday?
Conformis Inc. stock price yesterday was $2.26.
What is the PE ratio of Conformis Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Conformis Inc.’s P/E ratio is -0.40.
What is the Price-to-Book ratio of Conformis Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Conformis Inc. P/B ratio is 0.5560.
What is Conformis Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Conformis Inc.'s EBITDA is -0.47.
What is the 50-day moving average of Conformis Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Conformis Inc. 50-day moving average is $2.23.
